Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial

被引:81
作者
Atkinson, M. [1 ]
Lakhanpaul, M.
Smyth, A.
Vyas, H.
Weston, V.
Sithole, J.
Owen, V.
Halliday, K.
Sammons, H.
Crane, J.
Guntupalli, N.
Walton, L.
Ninan, T.
Morjaria, A.
Stephenson, T.
机构
[1] Univ Nottingham, Univ Hosp, Queens Med Ctr, Div Child Hlth,Paediat Resp Unit, Nottingham NG7 2UH, England
[2] Univ Leicester, Div Child Hlth, Leicester, Leics, England
[3] City Hosp, Div Child Hlth, Nottingham NG5 1PB, England
[4] Univ Nottingham, Trent Res & Dev Support Unit, Nottingham NG7 2RD, England
[5] Derby Childrens Hosp, Div Child Hlth, Derby, England
[6] New Cross Hosp, Wolverhampton, W Midlands, England
[7] United Lincolnshire Hosp NHS Trust, Lincoln, England
[8] Kings Mill Hosp, Mansfield, PA USA
[9] Birmingham Heartlands & Solihull Hosp, Birmingham, W Midlands, England
[10] Univ Hosp N Staffordshire, Stoke On Trent, Staffs, England
关键词
D O I
10.1136/thx.2006.074906
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective: To ascertain whether therapeutic equivalence exists for the treatment of paediatric community acquired pneumonia by the oral and intravenous (IV) routes. Methods: A multicentre pragmatic randomised controlled non-blinded equivalence trial was undertaken in eight paediatric centres in England (district general and tertiary hospitals). Equivalence was defined as no more than a 20% difference between treatments of the proportion meeting the primary outcome measure at any time. 246 children who required admission to hospital and had fever, respiratory symptoms or signs and radiologically confirmed pneumonia were included in the study. Exclusion criteria were wheeze, oxygen saturations <85% in air, shock requiring >20 ml/kg fluid resuscitation, immunodeficiency, pleural effusion at presentation requiring drainage, chronic lung condition (excluding asthma), penicillin allergy and age,6 months. The patients were randomised to receive oral amoxicillin for 7 days (n = 126) or IV benzyl penicillin (n = 120). Children in the IV group were changed to oral amoxicillin after a median of six IV doses and received 7 days of antibiotics in total. The predefined primary outcome measure was time for the temperature to be <38 degrees C for 24 continuous hours and oxygen requirement to cease. Secondary outcomes were time in hospital, complications, duration of oxygen requirement and time to resolution of illness. Results: Oral amoxicillin and IV benzyl penicillin were shown to be equivalent. Median time for temperature to settle was 1.3 days in both groups (p<0.001 for equivalence). Three children in the oral group were changed to IV antibiotics and seven children in the IV group were changed to different IV antibiotics. Median time to complete resolution of symptoms was 9 days in both groups. Conclusion: Oral amoxicillin is effective for most children admitted to hospital with pneumonia (all but those with the most severe disease who were excluded from this study). Prior to this study, the British Thoracic Society guidelines on childhood pneumonia could not draw on evidence to address this issue. This will spare children and their families the trauma and pain of cannulation, and children will spend less time in hospital.
引用
收藏
页码:1102 / 1106
页数:5
相关论文
共 19 条
  • [1] Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study
    Addo-Yobo, E
    Chisaka, N
    Hassan, M
    Hibberd, P
    Lozano, JM
    Jeena, P
    MacLeod, WB
    Maulen, I
    Patel, A
    Qazi, S
    Thea, DM
    Nguyen, NTV
    [J]. LANCET, 2004, 364 (9440) : 1141 - 1148
  • [2] Altman DG, 1998, BRIT MED J, V317, P468
  • [3] ETIOLOGY OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN BASED ON ANTIBODY-RESPONSES TO BACTERIAL AND VIRAL-ANTIGENS
    CLAESSON, BA
    TROLLFORS, B
    BROLIN, I
    GRANSTROM, M
    HENRICHSEN, J
    JODAL, U
    JUTO, P
    KALLINGS, I
    KANCLERSKI, K
    LAGERGARD, T
    STEINWALL, L
    STRANNEGARD, O
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1989, 8 (12) : 856 - 862
  • [4] Children with pneumonia: how do they present and how are they managed?
    Clark, Julia E.
    Hammal, Donna
    Spencer, David
    Hampton, Fiona
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (05) : 394 - 398
  • [5] Rationalised prescribing for community acquired pneumonia: a closed loop audit
    Clements, H
    Stephenson, T
    Gabriel, V
    Harrison, T
    Millar, M
    Smyth, A
    Tong, W
    Linton, CJ
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2000, 83 (04) : 320 - 324
  • [6] Community acquired pneumonia - a prospective UK study
    Drummond, P
    Clark, J
    Wheeler, J
    Galloway, A
    Freeman, R
    Cant, A
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2000, 83 (05) : 408 - 412
  • [7] Leptin and the obesity hypoventilation syndrome: a leap of faith?
    Fitzpatrick, M
    [J]. THORAX, 2002, 57 (01) : 1 - 2
  • [8] Utility of blood cultures in pediatric patients found to have pneumonia in the emergency department
    Hickey, RW
    Bowman, MJ
    Smith, GA
    [J]. ANNALS OF EMERGENCY MEDICINE, 1996, 27 (06) : 721 - 725
  • [9] INCIDENCE OF COMMUNITY-ACQUIRED PNEUMONIA IN THE POPULATION OF 4 MUNICIPALITIES IN EASTERN FINLAND
    JOKINEN, C
    HEISKANEN, L
    JUVONEN, H
    KALLINEN, S
    KARKOLA, K
    KORPPI, M
    KURKI, S
    RONNBERG, PR
    SEPPA, A
    SOIMAKALLIO, S
    STEN, M
    TANSKA, S
    TARKIAINEN, A
    TUKIAINEN, H
    PYORALA, K
    MAKELA, PH
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (09) : 977 - 988
  • [10] Etiology of community-acquired pneumonia in 254 hospitalized children
    Juvén, T
    Mertsola, J
    Waris, M
    Leinonen, M
    Meurman, O
    Roivainen, M
    Eskola, J
    Saikku, P
    Ruuskanen, O
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (04) : 293 - 298